SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-016519
Filing Date
2017-08-08
Accepted
2017-08-08 16:10:36
Documents
2
Period of Report
2017-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K Q2 2017 ER orex-8k_20170809.htm 8-K 40198
2 EX-99.1 orex-ex991_15.htm EX-99.1 349120
  Complete submission text file 0001564590-17-016519.txt   390469
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33415 | Film No.: 171014826
SIC: 2834 Pharmaceutical Preparations